VeriDose DPYD Plus Panel - Agena Bioscience

Advanced DPYD Pharmacogenomics Research

The VeriDose^® DPYD Plus Panel on the MassARRAY^® System delivers comprehensive DPYD variant analysis for pharmacogenomics research laboratories worldwide. Designed specifically for research applications, this panel includes all Association for Molecular Pathology (AMP) Tier 1 and Tier 2 recommended variants plus four additional future-proofing variants, ensuring your genomics research captures the complete spectrum of clinically relevant DPYD polymorphisms.

Learn more about DPYD population diversity and research applications where we cover the latest insights on variant frequencies across global populations and their implications for precision medicine research.

Why Laboratories Choose VeriDose DPYD Plus Panel

Comprehensive Variant Coverage – Complete AMP Tier 1 & 2 variant coverage plus 4 additional future-proofing variants ensures your research captures all relevant DPYD polymorphisms across diverse populations.
Cost-Effective Research – Targeted approach eliminates reagent waste with no minimum batch requirements. Significant cost savings compared to NGS platforms for focused pharmacogenomics research.
Streamlined Workflow – Built-in bioinformatics analysis eliminates infrastructure overhead. Simple plate-based setup with all targets analyzed in a single well per research sample.
Scalable Solution – Flexible sample processing from single specimens to high-throughput studies. Run 1 to 1000+ samples in a single day across 96 or 384 well formats.

Platform Comparison for DPYD Research

Panel Resources

Product Brochure

Ordering Information

Product	# of Samples	Format	Catalog #
VeriDose DPYD Plus Panel Set – CPM (2x96)	192	96 CPM	13392F
VeriDose DPYD Plus Panel Set – CPM (10x96)	960	96 CPM	13399F
VeriDose DPYD Plus Panel Set – CPM (2x384)	768	384 CPM	13393D
VeriDose DPYD Plus Panel Set – CPM (10x384)	3,840	384 CPM	13395D

Request A Quote

Resources:

Explore how expanded DPYD testing is changing PGx research

Learn More

Publication:

DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical...

View on ScienceDirect.com

Explore broader PGx coverage with VeriDose Core 2.0

If your research goes beyond DPYD, or if you’re developing a wider pharmacogenomics program, the VeriDose^® Core v2.0 Panel offers a next-generation solution.

Designed for pan-ethnic PGx studies, this RUO panel includes 85 variants across 16 genes, aligned with AMP Tier 1 and Tier 2 guidelines, CPIC recommendations, and FDA considerations. It also enables the direct detection of HLA alleles and VNTRs, allowing researchers to investigate high-impact variants often overlooked by traditional panels.

Whether you’re focused on drug metabolism, hypersensitivity, or enhancing cohort representation, VeriDose^® Core v2.0 Panel provides:

Comprehensive PGx content covering CYP2C9, CYP2C19, CYP2D6, TPMT, DPYD, HLA and more
Scalable workflows compatible with the MassARRAY^® System
Proven performance across low-quality and saliva DNA samples (>95% concordance in beta site testing)
Streamlined implementation – no need for custom assays or revalidation

The VeriDose^® DPYD Plus Panel and VeriDose^® Core v2.0 Panel are part of Agena’s expanding PGx research portfolio, designed to help labs lead the next phase of pharmacogenomics. Whether you’re targeting a single high-risk gene like DPYD, addressing complex targets like CYP2D6, or expanding to multi-gene, pan-ethnic studies, these panels provide consistency, speed, and confidence, powered by the MassARRAY^® System.

Advanced DPYD Pharmacogenomics Research

Why Laboratories Choose VeriDose DPYD Plus Panel

Platform Comparison for DPYD Research

Panel Resources

Ordering Information

Resources:

Publication:

Explore broader PGx coverage with VeriDose Core 2.0

Support

WHITE PAPER

VeriDose® DPYD Plus Panel

Advanced DPYD Pharmacogenomics Research

Why Laboratories Choose VeriDose DPYD Plus Panel

Platform Comparison for DPYD Research

Panel Resources

Ordering Information

Resources:

Publication:

Explore broader PGx coverage with VeriDose Core 2.0

VeriDose^® DPYD Plus Panel